Big Profits Await as Drug Manufacturing Comes Home

By Ray BlancoPosted April 1, 2021

COVID-19 exposed the underbelly of the pharmaceutical industry. As 80% of active ingredients in drugs are made in India and China, the need for reshoring this manufacturing was never higher than the last year. And with a push from lawmakers, we could see a major shift in drug manufacturing in the coming years. Today's picks look to capitalize on this shift.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Technology & Biotech Lead 2020

By Ray BlancoPosted July 1, 2020

The first half of the year has been crazy. So as we head into the second half of the year, I’ve compiled updates on our current portfolio — including new buy-up-to prices. If you missed the original recommendations, now’s your chance to get in on many of these plays.

Profiting From This Decade’s Fastest Growing Market

By Ray BlancoPosted April 28, 2011

You know how excited I am about the technological transformation in wireless data and mobile computing. Wireless and mobile represent a profits happy hunting ground too important to ignore. In this month's issue, I have another company that is profiting from an accelerating demand in mobile technology.

The “Boring” Company Curing the Fungus Among Us

By Ray BlancoPosted May 1, 2014

Although it’s right next to carbon on the periodic table, boron has never been a particularly popular element for treating disease in carbon-based life. Boron’s been rather boring from a medical perspective. In other industries, that’s not the case. Borax, a compound of boron and sodium, is present in many cleaning products. And boron is an important element in the manufacture of glass and ceramics as well as in composites used in the aerospace industry. Fibers used in golf clubs, fishing rods and body armor also use the element’s unique attributes to grant strength.

The Great Technology War of the 21st Century

By Ray BlancoPosted March 1, 2019

In this month's issue, Ray covers how the U.S. is trying to keep up in the new tech race, a new buy with a history of outperformance, and two great tech companies that have teamed up to create something amazing...

One Company Ready to Rocket Higher

By Ray BlancoPosted February 7, 2020

Internet companies have a stranglehold on the market. And their next big is going to be 5G. But due to a multitude of reasons, it’ll be ferociously expensive to deploy — estimated at $10 billion or more. To help this technology, there’s another lucrative sector out there who’s innovation can help propel 5G deployment to new heights… And it’s coming from a household name new to the whole scene.

Emerging SMDC Technology Will Be Vitamins for Your Portfolio

By Ray BlancoPosted July 31, 2012

Over a year ago, I told you about two companies pioneering a new therapeutic platform that provides the benefits of chemotherapy while reducing the side effects. Many of you are familiar with the innovators of these new biological "magic bullets": ImmunoGen (NASDAQ:IMGN) and Seattle Genetics (NASDAQ:SGEN). Both companies specialize in antibody-drug conjugates (ADCs), a biotechnology that works against cancer by linking antibodies to powerful toxins. The antibody is engineered in the lab to hone in on proteins found on the surface of cancer cells. Once the antibody attaches to a cancerous cell, it is drawn inside, where the toxin is released to kill it.

Login